AMY SMITH: Open Payments
NPI 1841060852 · LARAMIE, WY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,205 in 49 payments from 24 companies in 2025. Trend: 2023 $121 · 2024 $1,759 · 2025 $1,205
Food & beverage: $921Education: $284
| Company | Payments | Amount |
|---|---|---|
| SEAGEN INC. | 2 | $185 |
| Janssen Biotech, Inc. | 7 | $172 |
| PFIZER INC. | 7 | $125 |
| Merck Sharp & Dohme LLC | 4 | $102 |
| Sumitomo Pharma America, Inc. | 3 | $77 |
| Novartis Pharmaceuticals Corporation | 3 | $59 |
| AstraZeneca Pharmaceuticals LP | 2 | $52 |
| Eisai Inc. | 2 | $49 |
| Pharmacosmos Therapeutics Inc. | 2 | $40 |
| Siemens Medical Solutions USA, Inc. | 1 | $37 |
Products named: DARZALEX, KEYTRUDA, ORGOVYX, KISQALI, Lenvima, MONOFERRIC, ELREXFIO, TrueBeam.
Industry payments across WY — which companies pay providers there.
